Stock listing

Insmed Incorporated

Selected listing: IM8N · DUS · EUR · DE

Insmed Incorporated (Dusseldorf:IM8N), Health Technology. Latest release Oct 5, 2026: Insmed Announces CFO Transition.

IM8N:DUSEURDEUpdated October 2, 2026

Ticker: Dusseldorf:IM8N
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Dusseldorf
Currency: EUR

About Insmed Incorporated

The company focuses on developing innovative therapies for patients with serious diseases. Insmed is committed to advancing its pipeline and improving patient outcomes through its research and development efforts.

Latest news from Insmed Incorporated

Insmed Announces CFO Transition

October 4, 2026

Insmed Announces CFO Transition

October 5, 2026

FDA Grants Priority Review to Insmed's sNDA for ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of MAC Lung Disease With PDUFA Target Action Date Set for January 28, 2027

September 21, 2026

Insmed Expands Community Impact During Fifth Annual Global Day of Good

September 16, 2026

Insmed to Present Data Across Its Respiratory Portfolio, Including New Late-Breaking ARIKAYCE® (amikacin liposome inhalation suspension) Results From Phase 3b ENCORE Study at the European Respiratory Society Congress 2026

September 3, 2026

All Insmed Incorporated news →

Events

Replays

Insmed Incorporated (INSM) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 08:00 AM ET
Watch
Insmed Incorporated (INSM) Q1 2026 Earnings Call
Thu, May 07, 2026 · 08:00 AM ET
Watch
Insmed Incorporated (INSM) Q4 2025 Earnings Call
Thu, Feb 19, 2026 · 08:00 AM ET
Watch

Research Insmed Incorporated

Insmed Incorporated company profile

View the public company page for Insmed Incorporated on 6ix.

Insmed Incorporated news

Read company news and market updates connected to Insmed Incorporated.

Insmed Incorporated investor events

Find investor webinars, events, and replay context for Insmed Incorporated.